Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SRT2104 in Type 2 Diabetes
NCT01018017Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SRT2104 in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Mar 2010; status: completed.
02
Drugs
SRT2104
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01018017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018017.